Eosinophil-to-Lymphocyte Ratio and Eosinophil Count as New Predictive Markers for Osteoarthritis
Jingkai Di,Liying Song,Yaru Liu,Zhibo Zhang,Yawen Wu,Tingting Chen,Chuan Xiang
DOI: https://doi.org/10.2147/jpr.s480925
IF: 2.8319
2024-11-23
Journal of Pain Research
Abstract:Jingkai Di, 1, 2, &ast Liying Song, 2, 3, &ast Yaru Liu, 2, 4, &ast Zhibo Zhang, 1, 2 Yawen Wu, 2 Tingting Chen, 2, 5 Chuan Xiang 1 1 The Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China; 2 Shanxi Medical University, Taiyuan, People's Republic of China; 3 The First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China; 4 The Third Hospital of Shanxi Medical University, Taiyuan, People's Republic of China; 5 The Fifth Hospital of Shanxi Medical University, Taiyuan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chuan Xiang, The Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China, Tel +86 15903410351, Email Purpose: Despite the association between peripheral blood inflammatory biomarkers and a range of inflammatory diseases, the role of these biomarkers in osteoarthritis (OA) progression remains unclear. Additionally, whether alterations in these inflammatory markers impact the prognosis of OA patients remains an understudied area. The aim of our study was to investigate the specific associations between peripheral blood inflammatory markers and OA progression and OA-related mortality. Methods: Data were obtained from the National Health and Nutrition Examination Survey (NHANES) database from 1999 through 2018. The primary outcomes were all-cause mortality, cardiac mortality, and renal disease mortality, with information on the corresponding mortality rates for each participant obtained through association with the National Death Index (NDI). Multivariate logistic regression models were used to examine the relationship between peripheral blood lymphocyte counts and OA, and restricted cubic spline (RCS) analysis was utilized to assess whether there was a nonlinear relationship with OA and mortality of OA patients. Interaction and stratified analyses were employed to explore the association between peripheral blood leukocyte counts and OA. Results: This study included 1077 OA patients and 21,612 non-OA participants. In model 3 fully adjusted for covariates, eosinophil-to-lymphocyte ratio (ELR) and eosinophil (EOS) were positive risk factors promoting the development of OA (OR = 3.26, 95% CI: 1.49– 7.14; OR = 1.79, 95% CI: 1.12– 2.88). In stratified models for age, sex, BMI, smoking status, and alcohol consumption, the associations of ELR and EOS with OA were significantly different. RCS curves showed a J-shaped relationship between ELR and EOS and all-cause mortality in patients with OA. ELR was also found to significantly up-regulate cardiac mortality and renal mortality in patients with OA (OR = 3.92, 95% CI: 1.68– 9.14; OR = 22.55, 95% CI: 6.55– 77.70), while EOS was only significantly positively correlation (OR = 3.68, 95% CI: 1.94– 7.01). Conclusion: A significant relationship was found between ELR, EOS and OA. In addition, ELR and EOS were identified as potential predictors of mortality from different causes in patients with OA. Keywords: eosinophil to lymphocyte ratio, osteoarthritis, eosinophil, all-cause mortality Osteoarthritis (OA) is a burdensome degenerative disease that can lead to irreversible progressive destruction of articular cartilage. 1 It is characterized by meniscal degeneration, subchondral bone remodeling, infrapatellar fat pad fibrosis and inflammation, which severely limits the quality of life of those affected. 2,3 Data from the UK OA Survey suggest that up to 8.75 million people in the population have symptomatic OA, for which there is no cure other than non-steroidal anti-inflammatory drugs to relieve symptoms. 4,5 OA is a growing public health problem worldwide, affecting more than half of the population over the age of 65. 6 An estimate of the burden in 2018 put the total annual cost of treating OA at 20.9 billion in the UK, and as high as $142.1 billion in the US. 7 Unfortunately, OA is currently diagnosed on the basis of pain and radiographic findings, both of which are usually seen in the later stages of the disease when it is more difficult to treat. 8 Therefore, the identification of new potential bioindicators or risk factors for OA is urgent and necessary. OA is a complex chronic disease. One of the most evident reasons in the pathogenesis of osteoarthritis is frequently age, but as research has advanced, it has become clear that other moderate to severe risk factors include heredity, obesity, and pre-existing traumas. 9–11 Furthermore, it h -Abstract Truncated-
clinical neurology